샘플 요청 목록

 카트 문의
시장보고서
상품코드
1877462

세계의 POC(Point of Care) 응고 검사 시장 : 검사 유형별, 기술별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율 및 예측(2025-2032년)

Point-of-Care Coagulation Testing Market, By Test Type, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 390 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

POC(Point of Care) 응고 검사 시장 규모는 2024년에 27억 9,878만 달러로 평가되었고, 2025-2032년 6.5%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예측됩니다.

현장 응고 검사(POCCT)는 신속한 병상 내 혈액 응고 분석을 제공하고 즉각적인 데이터에 기반한 임상적 판단을 가능하게 함으로써 의료계에 혁신을 가져오고 있습니다. 응급상황, 수술, 출혈성 질환에서 환자 치료의 개별화를 위한 신속하고 정확한 응고 진단에 대한 수요 증가는 연결성, 소형화, AI 통합의 지속적인 혁신에 힘입어 시장 성장을 가속하고 있습니다. 또한, 시장에서 종합적인 응고 프로파일을 제공하고 외상 및 외과적 치료 결과를 개선하는 고급 점탄성 검사로 전환하는 추세도 눈에 띄게 나타나고 있습니다. 만성질환 환자들의 편리한 치료 관리를 돕는 재택 항응고제 모니터링의 확대는 주요 성장 기회입니다. 그러나 중앙 검사실 환경 외의 검사 수행 시에는 일관되고 엄격한 품질 관리를 유지하는 것이 과제입니다.

현장 응고 검사 시장 역학

심혈관 질환 증가 추세

심부정맥혈전증, 뇌졸중, 심방세동과 같은 심혈관 질환은 전 세계적으로 사망과 이환의 주요 원인이 되고 있습니다. 세계보건기구(WHO)가 2025년 7월 발표한 자료에 따르면, 전 세계적으로 심혈관질환(CVD)은 사망의 주요 원인으로 꼽힙니다. 2022년에는 전 세계적으로 약 1,980만 명이 CVD로 인해 사망할 것으로 예상되며, 이는 전체 사망자 수의 약 32%를 차지합니다. 이 중 85%는 심근경색과 뇌졸중으로 인한 것이었습니다. 또한, 2021년 비감염성 질환으로 인한 조기 사망(70세 미만) 1,800만 건 중 최소 38%는 CVD로 인한 것으로 추정됩니다. 따라서 출혈이나 혈전증과 같은 치명적인 부작용을 예방하기 위해서는 프로트롬빈 시간(PT/INR), 활성화 응고 시간(ACT) 등의 응고 파라미터를 주기적으로 모니터링하는 효과적인 항응고 요법이 필수적입니다. 그러나 기존 검사실 검사에 따른 중앙집중식 인프라와 긴 결과 대기시간은 중요한 치료 결정을 지연시킬 수 있습니다. 이러한 문제를 해결하는 것이 바로 POC 응고 검사로, 환자의 침대 옆, 수술실, 응급실, 응급실, 심지어 집에서도 몇 분 안에 결과를 확인할 수 있습니다. 이를 통해 입원율 감소와 더불어 특히 장기 항응고제 복용 환자의 치료 순응도를 향상시킬 수 있습니다.

Point-of-Care 응고 검사 시장 : 세분화 분석

세계 현장 응고 검사 시장은 검사 유형, 기술, 최종 사용자, 지역을 기준으로 세분화됩니다.

검사 유형에 따른 시장 분석은 프로트롬빈 시간(PT/INR) 검사, 활성화 응고 시간(ACT) 검사, 활성화 부분 트롬보플라스틴 시간(aPTT) 검사, 점탄성 검사(TEG, ROTEM 등), 기타 특수 응고 검사 등 5가지 카테고리로 나뉩니다. PT/INR은 외인성 경로와 와파린을 모니터링하고, ACT는 고용량 헤파린의 투여 지침이 되며, aPTT는 내인성 경로와 헤파린을 확인하고, TEG/ROTEM은 응고 동태를 분석하며, 기타는 특정 질환을 대상으로 합니다.

시장은 기술에 따라 광학 기술, 기계 기술, 전기화학 기술 등 세 가지 범주로 나뉩니다. 광학 기술은 빛의 변화와 패턴을 측정하여 응고를 감지합니다. 기계 기술은 혈액의 점도와 움직임을 평가하여 혈전 형성을 나타냅니다. 전기화학 기술은 응고 과정에서 전기적 변화를 감지합니다.

Point-of-Care 응고 검사 시장 - 지역별 분석

북미는 선진화된 의료 인프라, 광범위한 도입, 출혈성 질환의 높은 유병률에 힘입어 시장을 주도하고 있습니다. 또한, 신속한 진단, 항응고제 관리, 강력한 의료 투자 등에 대한 중요성이 강조되면서 북미에서는 현장 응고 검사가 널리 채택되고 있습니다. 유럽에서는 영국을 비롯한 서유럽 국가들이 빠른 성장세를 보이고 있습니다. 이는 정부의 장려책, 만성질환의 자가 관리 도입 증가, 특히 항응고 요법 및 수술에서 신속하고 신뢰할 수 있는 모니터링에 대한 수요가 증가하고 있기 때문입니다. 아시아태평양은 의료 접근성 확대, 심혈관 응고 검사 의무화, 출혈성 질환 및 혈전성 질환의 신속한 관리가 필요한 환자 수 증가를 배경으로 가장 빠른 성장이 예상됩니다. 라틴아메리카의 현장 진료 응고 검사 시장은 신속한 질병 발견과 효과적인 관리에 대한 투자로 인해 꾸준히 성장하고 있습니다. 중동 및 아프리카에서는 뇌졸중 관리 프로그램 개발 및 전문 시설에서 카트리지형 응고 검사에 대한 관심이 높아짐에 따라 수요가 증가하는 추세입니다.

Point-of-Care 응고 검사 시장 : 경쟁 구도

현장응고검사(POC, Point of Care) 시장은 임상 현장과 가정에서 신속하고 정확한 응고 평가에 대한 수요가 증가함에 따라 치열한 경쟁으로 급성장하고 있습니다. 주요 기업으로는 F. Hoffman-La Roche, Abbott Laboratories, Siemens Healthcare, Sysmex, Welfen 등이 있으며, 모두 마이크로플루이딕스, 바이오센서, AI 통합 등 첨단 기술을 통한 제품 포트폴리오 확장에 주력하고 있습니다. 이들 기업은 의료 시스템과의 원활한 통합을 위해 기기의 정확성, 휴대성, 연결성을 향상시키기 위해 연구, 혁신, 전략적 제휴에 많은 투자를 하고 있습니다. 예를 들어, 2022년 1월, F. 호프만 라 로슈는 CE 마크 승인을 받아 일부 국가에서 cobas pulse 시스템 출시를 발표하였습니다. 이 새로운 시스템은 전문적인 혈당 관리를 위해 특별히 설계된 로슈진단의 최신 커넥티드 포인트 오브 케어(Connected Point of Care) 솔루션입니다. 또한, 이 시장은 소수의 대형 제조업체가 상당한 점유율을 차지하고 다수의 소규모 기업이 틈새 분야에서 경쟁하는 반집적 구조가 특징입니다.

목차

제1장 POC(Point of Care) 응고 검사 시장 개요

  • 분석 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 POC(Point of Care) 응고 검사 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 향후 동향

제4장 POC(Point of Care) 응고 검사 시장 : 산업 분석

  • PEST 분석
  • Porter의 Five Forces 분석
  • 시장 성장 전망 : 맵핑
  • 규제 체제 분석

제5장 POC(Point of Care) 응고 검사 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 POC(Point of Care) 응고 검사 시장 구도

  • POC(Point of Care) 응고 검사 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 POC(Point of Care) 응고 검사 시장 : 검사 유형별

  • 개요
    • 부문별 점유율 분석 : 검사 유형별
    • 프로트롬빈 시간(PT/INR) 검사
    • 활성화 응고 시간(ACT) 검사
    • 활성화 부분 트롬보플라스스틴 시간(aPTT) 검사
    • 점탄성 시험(TEG, ROTEM 등)
    • 기타 특수 응고 검사

제8장 POC(Point of Care) 응고 검사 시장 : 기술별

  • 개요
    • 부문별 점유율 분석 : 기술별
    • 광학 기술
    • 기계 기술
    • 전기화학 기술

제9장 POC(Point of Care) 응고 검사 시장 : 최종사용자별

  • 개요
    • 부문별 점유율 분석 : 최종사용자별
    • 병원 및 클리닉
    • 외래수술센터(ASC)
    • 진단실험실
    • 가정치료 환경
    • 기타

제10장 POC(Point of Care) 응고 검사 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : POC(Point of Care) 응고 검사 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • Siemens Healthineers
    • Abbott Laboratories
    • Sysmex Corporation
    • Werfen
    • Danaher Corporation
    • Medtronic
    • HemoSonics, LLC
    • Danaher Corporation
    • Trinity Biotech
    • F. Hoffmann-La Roche Ltd

제12장 AnalystView의 전방위적 분석

LSH 25.12.22

Point-of-Care Coagulation Testing Market size was valued at US$ 2,798.78 Million in 2024, expanding at a CAGR of 6.5% from 2025 to 2032.

Point-of-Care Coagulation Testing (POCCT) is revolutionizing healthcare by providing rapid, bedside blood clotting analysis that enables immediate, data-driven clinical decisions. The rising demand for fast, accurate coagulation diagnostics to personalize patient care in emergencies, surgeries, and bleeding disorders, supported by continuous innovation in connectivity, miniaturization, and AI integration is boosting market growth. Additionally, the market is witnessing a significant trend toward sophisticated viscoelastic testing that offers a comprehensive clot profile, improving trauma and surgical outcomes. A major growth opportunity lies in expanding home-based anticoagulant monitoring, empowering patients with chronic conditions to manage therapy conveniently. However, the market faces challenges in maintaining consistent and rigorous quality control when testing occurs outside centralized laboratory settings.

Point-of-Care Coagulation Testing Market- Market Dynamics

Growing prevalence of cardiovascular diseases

Globally, cardiovascular diseases such deep vein thrombosis, stroke, and atrial fibrillation are leading causes of death and morbidity. According to data published in July 2025, by World Health Organization (WHO), globally, cardiovascular diseases (CVDs) constitute the primary cause of mortality. About 19.8 million deaths worldwide in 2022 were attributed to CVDs, accounting for about 32% of the total number of deaths. Heart attacks and strokes were the cause of 85% of these fatalities. Moreover, CVDs were responsible for at least 38% of the 18 million premature deaths (those under 70) that occurred in 2021 as a result of noncommunicable diseases. Thus, in order to prevent potentially fatal side effects like bleeding or thrombosis, effective anticoagulation therapy necessitates routine monitoring of clotting parameters including Prothrombin Time (PT/INR) and Activated Clotting Time (ACT). However, centralized infrastructure and longer turnaround times associated with traditional laboratory testing may cause important treatment choices to be postponed. These obstacles are addressed by POC coagulation tests, which provide results in a matter of minutes at the patient's bedside, operating room, emergency hospital, or even their home. In addition to decreasing hospitalizations, this also improves patient adherence, particularly for long-term anticoagulant users.

Point-of-Care Coagulation Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2025-2032)

Based on Test Type segmentation, Prothrombin Time (PT/INR) Testing is predicted to show maximum market share in the year 2024

Based on Technology segmentation, Optical Technology is the leading Technology in 2024

Based on End User segmentation, Hospitals & Clinics is the leading Technology in 2024

On the basis of region, North America is the leading revenue generator in 2024

Point-of-Care Coagulation Testing Market- Segmentation Analysis:

The Global Point-of-Care Coagulation Testing Market is segmented on the basis of Test Type, Technology, End User, and Region.

The market is divided into five categories based on Test Type: Prothrombin Time (PT/INR) Testing, Activated Clotting Time (ACT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, Viscoelastic Testing (TEG, ROTEM, etc.), and Other Specialized Coagulation Tests. PT/INR monitors extrinsic pathway and warfarin, ACT guides high-dose heparin, aPTT checks intrinsic pathway and heparin, TEG/ROTEM analyze clot dynamics, others target specific disorders.

The market is divided into three categories based on Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology. Optical technology measures light changes or patterns to detect clotting; mechanical technology assesses blood viscosity or movement to indicate clot formation; electrochemical technology detects electrical changes during coagulation.

Point-of-Care Coagulation Testing Market- Geographical Insights

North America dominates the market, driven by advanced healthcare infrastructure, widespread adoption, and a high prevalence of bleeding disorders. Additionally, North America exhibits widespread adoption of point-of-care coagulation testing due to the emphasis on rapid diagnosis, anticoagulant therapy management, and strong healthcare investments, among others. The UK and other Western nations are experiencing rapid growth in Europe as a result of encouraging government measures, increasing adoption of self-monitoring for chronic conditions, and demand for rapid, reliable monitoring, especially in anticoagulation therapy and surgery. Asia-Pacific is expected to witness the fastest growth, fueled by expanding healthcare access, mandates for cardiovascular clotting tests, and larger patient populations requiring rapid management of bleeding and thrombotic disorders. The Latin American point-of-care coagulation testing market is expanding steadily, owing to investment in rapid disease detection and effective management. Middle East and Africa, show rising demand, due to stroke management programs and an increasing focus on cartridge-based coagulation tests in specialty centers.

Point-of-Care Coagulation Testing Market- Competitive Landscape:

The point-of-care (POC) coagulation testing market is highly competitive and rapidly growing, driven by increasing demand for quick, accurate clotting assessments in clinical and home settings. Key players include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, and Werfen, all focusing on expanding product portfolios through advanced technologies such as microfluidics, biosensors, and AI integration. These companies invest significantly in research, innovation, and strategic collaborations to enhance device accuracy, portability, and connectivity, enabling seamless integration with healthcare systems. For instance, in January 2022, F. Hoffmann-La Roche Ltd has announced the launch of the cobas pulse system in select countries with CE Mark approval. This new system represents Roche Diagnostics' latest generation of connected point-of-care solutions designed specifically for professional blood glucose management. Additionally, the market is characterized by a semi-consolidated structure, with a few dominant manufacturers holding substantial shares while numerous smaller companies compete in niche segments.

Recent Developments:

In July 2024, Werfen introduced GEM Premier 7000 with Intelligent Quality Management 3 (iQM3). The GEM Premier 7000 with iQM3 represented a breakthrough in blood gas testing, and offered hemolysis detection for first time at the point-of-care (POC).

In March 2023, Siemens Healthineers and Sysmex Corporation have established a global Original Equipment Manufacturer (OEM) agreement to supply hemostasis instruments and reagents. The strengthened collaboration leveraged their 25-year partnership to improve patient outcomes by advancing hemostasis testing technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Siemens Healthineers
  • Abbott Laboratories
  • Sysmex Corporation
  • Werfen
  • Danaher Corporation
  • Medtronic
  • HemoSonics, LLC
  • Danaher Corporation
  • Trinity Biotech
  • F. Hoffmann-La Roche Ltd
  • Others

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prothrombin Time (PT/INR) Testing
  • Activated Clotting Time (ACT) Testing
  • Activated Partial Thromboplastin Time (aPTT) Testing
  • Viscoelastic Testing (TEG, ROTEM, etc.)
  • Other Specialized Coagulation Tests

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Laboratories
  • Home Care Settings
  • Others

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Point-of-Care Coagulation Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Point-of-Care Coagulation Testing Market Snippet by Test Type
    • 2.1.2. Point-of-Care Coagulation Testing Market Snippet by Technology
    • 2.1.3. Point-of-Care Coagulation Testing Market Snippet by End User
    • 2.1.4. Point-of-Care Coagulation Testing Market Snippet by Country
    • 2.1.5. Point-of-Care Coagulation Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Point-of-Care Coagulation Testing Key Market Trends

  • 3.1. Point-of-Care Coagulation Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Point-of-Care Coagulation Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Point-of-Care Coagulation Testing Market Opportunities
  • 3.4. Point-of-Care Coagulation Testing Market Future Trends

4. Point-of-Care Coagulation Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Point-of-Care Coagulation Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Point-of-Care Coagulation Testing Market Landscape

  • 6.1. Point-of-Care Coagulation Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Point-of-Care Coagulation Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Prothrombin Time (PT/INR) Testing
    • 7.1.3. Activated Clotting Time (ACT) Testing
    • 7.1.4. Activated Partial Thromboplastin Time (aPTT) Testing
    • 7.1.5. Viscoelastic Testing (TEG, ROTEM, etc.)
    • 7.1.6. Other Specialized Coagulation Tests

8. Point-of-Care Coagulation Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Optical Technology
    • 8.1.3. Mechanical Technology
    • 8.1.4. Electrochemical Technology

9. Point-of-Care Coagulation Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Home Care Settings
    • 9.1.6. Others

10. Point-of-Care Coagulation Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Point-of-Care Coagulation Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Point-of-Care Coagulation Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Point-of-Care Coagulation Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Point-of-Care Coagulation Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Point-of-Care Coagulation Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Point-of-Care Coagulation Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Siemens Healthineers
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Sysmex Corporation
    • 11.2.4. Werfen
    • 11.2.5. Danaher Corporation
    • 11.2.6. Medtronic
    • 11.2.7. HemoSonics, LLC
    • 11.2.8. Danaher Corporation
    • 11.2.9. Trinity Biotech
    • 11.2.10. F. Hoffmann-La Roche Ltd

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제